Skip to Content
Rank 1139
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address INDUSTRIEPARK ZQIJNAARDE 7, BUILDING C B-9052, ZWIJNAARDE, BELGIUM

Argenx - Key figures

Market cap 14.46 Billion
Revenue 510.08 Million
Profit -270,945,000
P/E Ratio No information
P/s Ratio 28.36
Buy $ARGX at eToro

Argenx - Description

argenx SE, a clinical-phase biotechnology company, focuses on the development of antibody-based therapies for the treatment of autoimmune diseases, hematology and cancer.

The company is headquartered in Breda, the Netherlands.